• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型次黄嘌呤与马来酸的超分子盐作为潜在减肥药。

A Novel Supramolecular Salt of Hypoxanthine with Maleic Acid as a Potential Weight-Loss Drug.

作者信息

Xue Fumin, Yuan Xinyue, Li Xingyi, Fang Shimin, Cheng Yan

机构信息

Shandong Analysis and Test Center, School of Pharmaceutical Sciences, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China.

School of Material Science and Engineering, Shandong Jianzhu University, Jinan 250101, China.

出版信息

Int J Mol Sci. 2025 Apr 30;26(9):4266. doi: 10.3390/ijms26094266.

DOI:10.3390/ijms26094266
PMID:40362503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071735/
Abstract

Improving the stability of drugs in the solid state, as well as improving their solubility and poor bioavailability, is highly physiologically relevant. In this study, we focused on enhancing the solubility of hypoxanthine (HYP) through salt formation resulting from the preparation of hypoxanthine-maleic acid salt (HYP-MAL). Single crystals were obtained through solvent evaporation methods, and DSC, TGA, PXRD, FT-IR, and H NMR spectra were used to characterize the samples. The salt system had higher solubility properties than HYP, with an equilibrium solubility in water that was roughly 2.4 times greater than that of HYP, but the salt's equilibrium solubility increased when the pH shifted from 7.4 to 1.2; additionally, from 0 to 10 min, the powder dissolution rate was 1.8 times that of HYP, resulting in increased bioavailability. The anti-obesity impact of HYP-MAL salt on obese mice was investigated, providing important insights for the development of future weight-loss medications.

摘要

提高药物在固态下的稳定性,以及改善其溶解性和低生物利用度,具有高度的生理相关性。在本研究中,我们专注于通过制备次黄嘌呤-马来酸盐(HYP-MAL)形成盐来提高次黄嘌呤(HYP)的溶解度。通过溶剂蒸发法获得单晶,并使用DSC、TGA、PXRD、FT-IR和H NMR光谱对样品进行表征。该盐体系比HYP具有更高的溶解性,在水中的平衡溶解度约为HYP的2.4倍,但当pH从7.4变为1.2时,该盐的平衡溶解度增加;此外,在0至10分钟内,粉末溶解速率是HYP的1.8倍,从而提高了生物利用度。研究了HYP-MAL盐对肥胖小鼠的抗肥胖作用,为未来减肥药物的开发提供了重要见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/7377727effcf/ijms-26-04266-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/87625ada4fe0/ijms-26-04266-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/f066c158634d/ijms-26-04266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/9fe4c8576814/ijms-26-04266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/94f8eb7ee37f/ijms-26-04266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/5702ff784a94/ijms-26-04266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/703197aba73b/ijms-26-04266-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/a4ad9c97d4a1/ijms-26-04266-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/7377727effcf/ijms-26-04266-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/87625ada4fe0/ijms-26-04266-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/f066c158634d/ijms-26-04266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/9fe4c8576814/ijms-26-04266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/94f8eb7ee37f/ijms-26-04266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/5702ff784a94/ijms-26-04266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/703197aba73b/ijms-26-04266-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/a4ad9c97d4a1/ijms-26-04266-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fcd/12071735/7377727effcf/ijms-26-04266-g007.jpg

相似文献

1
A Novel Supramolecular Salt of Hypoxanthine with Maleic Acid as a Potential Weight-Loss Drug.一种新型次黄嘌呤与马来酸的超分子盐作为潜在减肥药。
Int J Mol Sci. 2025 Apr 30;26(9):4266. doi: 10.3390/ijms26094266.
2
Improving the Solubility, Stability, and Bioavailability of Albendazole through Synthetic Salts.通过合成盐提高阿苯达唑的溶解度、稳定性和生物利用度。
Molecules. 2024 Jul 29;29(15):3571. doi: 10.3390/molecules29153571.
3
Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder.使用双螺杆熔融挤出机通过新型无溶剂方法连续制备1:1氟哌啶醇-马来酸盐
Mol Pharm. 2017 Apr 3;14(4):1278-1291. doi: 10.1021/acs.molpharmaceut.7b00003. Epub 2017 Mar 10.
4
Ethylenediamine Salt Enhances the Solubility and Dissolution of Flurbiprofen.乙二胺盐提高氟比洛芬的溶解度和溶出度。
ChemistryOpen. 2024 Jun;13(6):e202300262. doi: 10.1002/open.202300262. Epub 2024 Jan 12.
5
New Saccharin Salt of Chlordiazepoxide: Structural and Physicochemical Examination.地西泮新糖精盐的结构和物理化学研究。
Int J Mol Sci. 2022 Oct 10;23(19):12050. doi: 10.3390/ijms231912050.
6
Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.盐酸盐共晶:制备、表征和物理化学研究。
Pharm Dev Technol. 2013 Mar-Apr;18(2):443-53. doi: 10.3109/10837450.2012.696270. Epub 2012 Jun 11.
7
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.
8
Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement.机械化学应用于乙硫异烟胺的重新配方和放大生产:盐的选择与溶解度提高
Eur J Pharm Sci. 2016 Jan 1;81:149-56. doi: 10.1016/j.ejps.2015.10.007. Epub 2015 Oct 22.
9
Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.具有改善理化性质的双氟嗪-苯甲酸共晶体的制备、表征及评价
Pharm Res. 2014 Mar;31(3):566-78. doi: 10.1007/s11095-013-1181-6. Epub 2013 Sep 25.
10
Investigation of salt formation between memantine and pamoic acid: Its exploitation in nanocrystalline form as long acting injection.美金刚与帕莫酸成盐的研究:其纳米晶形式作为长效注射剂的开发。
Eur J Pharm Biopharm. 2016 Apr;101:62-71. doi: 10.1016/j.ejpb.2016.01.003. Epub 2016 Feb 2.

本文引用的文献

1
Formulation of new drug delivery systems for insulin from natural bioactive biocompatible polymers.基于天然生物活性生物相容性聚合物的胰岛素新型药物递送系统的研制。
Sci Rep. 2025 Jan 31;15(1):3941. doi: 10.1038/s41598-025-86938-4.
2
Supramolecular nanomedicines based on host-guest interactions of cyclodextrins.基于环糊精主客体相互作用的超分子纳米药物。
Exploration (Beijing). 2023 May 28;3(4):20210111. doi: 10.1002/EXP.20210111. eCollection 2023 Aug.
3
Anti-obesity drug discovery: advances and challenges.抗肥胖药物的发现:进展与挑战。
Nat Rev Drug Discov. 2022 Mar;21(3):201-223. doi: 10.1038/s41573-021-00337-8. Epub 2021 Nov 23.
4
: a program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals.用于分子晶体的 Hirshfeld 表面分析、可视化和定量分析的程序。
J Appl Crystallogr. 2021 Apr 27;54(Pt 3):1006-1011. doi: 10.1107/S1600576721002910. eCollection 2021 Jun 1.
5
Hepatic Accumulation of Hypoxanthine: A Link Between Hyperuricemia and Nonalcoholic Fatty Liver Disease.肝脏中次黄嘌呤的蓄积:高尿酸血症与非酒精性脂肪性肝病的关联。
Arch Med Res. 2021 Oct;52(7):692-702. doi: 10.1016/j.arcmed.2021.04.005. Epub 2021 May 6.
6
Hypoxanthine Induces Muscular ATP Depletion and Fatigue via UCP2.次黄嘌呤通过UCP2诱导肌肉ATP耗竭和疲劳。
Front Physiol. 2021 Mar 3;12:647743. doi: 10.3389/fphys.2021.647743. eCollection 2021.
7
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs.当前及即将上市的抗肥胖药物综合综述
Diabetes Metab J. 2020 Dec;44(6):802-818. doi: 10.4093/dmj.2020.0258. Epub 2020 Dec 23.
8
Solubility and Stability Advantages of a New Cocrystal of Berberine Chloride with Fumaric Acid.盐酸小檗碱与富马酸新型共晶的溶解性和稳定性优势
ACS Omega. 2020 Apr 6;5(14):8283-8292. doi: 10.1021/acsomega.0c00692. eCollection 2020 Apr 14.
9
Differential regulation of hypoxanthine and xanthine by obesity in a general population.肥胖人群中黄嘌呤和次黄嘌呤的差异调节。
J Diabetes Investig. 2020 Jul;11(4):878-887. doi: 10.1111/jdi.13207. Epub 2020 Feb 9.
10
Hypoxanthine Secretion from Human Adipose Tissue and its Increase in Hypoxia.人脂肪组织中的次黄嘌呤分泌及其在缺氧时的增加。
Obesity (Silver Spring). 2018 Jul;26(7):1168-1178. doi: 10.1002/oby.22202. Epub 2018 Jun 7.